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Summary
Objective: We have introduced and improved a transducer holder, named the Sonopod, for
transcranial color duplex sonography (TCDS) monitoring via both temporal/foraminal windows
(TW/FW). The objective is to clarify clinical usefulness and identify problems in TCDS-Sonopod
monitoring during the evaluation of brain tissue perfusion.
Methods: Brain tissue perfusion monitoring was evaluated in 11 patients (ages 31—94, mean 66).
After a bolus intravenous Levovist®, power modulation imaging (PMI) in all cases was evaluated
in comparison with second harmonic imaging (SHI) in two cases at the diencephalic horizontal
plain via the TWs on the basis of time—intensity curves (TICs) in ﬁve regions of interest (ROIs);
bilateral basal ganglia (BG) and thalamus (Th), and contra-lateral temporal lobe (TL). After a
SONOS5500 S3 transducer was installed in the Sonopod, acetazolamide (ACZ) cerebral vasore-
activity utilizing PMI was evaluated in 10 cases via the bilateral (ﬁve cases) and unilateral (ﬁve
cases) TWs. A total of 30 TICs were evaluated before/after ACZ administration.
Results: (1) All patients could be monitored continuously by one examiner. (2) We conﬁrmed
that PMI proves superior to SHI in quantitative evaluation of the bilateral hemispheres via the
unilateral TWs. (3) Brain tissue perfusion could be precisely quantiﬁed before/after ACZ in the
same ROIs. (4) TIC base-line drifts during monitoring were observed in 4 (seven TICs) of 10 (30
TICs) patients. However, ﬁxed-probe shifts during monitoring were easily readjustable and the
TIC recovered to the base-line in all cases. (5) Due to re-ﬁxation needed for contralateral TW
monitoring, it was not possible to evaluate completely in the same ROIs.
Conclusions: TCDS-Sonopod monitoring succeeds in continuously and quantitatively evaluating
precise and reproducible intracranial hemodynamics in the brain tissue.
© 2012 Elsevier GmbH.
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ompared to conventional transcranial Doppler sonogra-
hy (TCD), transcranial color duplex sonography (TCDS) is
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Figure 1 Transducer holder (Sonopod) for transcranial color
duplex sonography (TCDS) monitoring. We have developed and
improved the transducer holder (Sonopod) for TCDS monitoring
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graphics are shown in Table 1. After a 5ml-bolus Levovist®
injection (2.5 g, 400mg/ml) via the antecubital vein, power
modulation imaging (PMI) in all cases in comparison with
Table 1 Patient demographics.
Total patients: n = 11
Causes of brain injury
Cerebral infarction
(atherothrombotic 5, lacunar
2, embolic 1)
8
Hypertensive putaminal
hemorrhage
1
Ruptured anterior
communicating aneurysm
1
Chronic subdural hematoma 1
Ages: 31—94 years (mean 66)
Gender: male 9, female 2
Monitoring (via temporal window)
Perfusion imaging
Power modulation imaging
only
9
Second harmonic imaging
and Power modulation
imaging
2
Acetazolamide vasoreactivity
test (bilateral 5, unilateral 5)
10 (30 TIC analyses)(a and b).
able to measure much more accurately on the basis of
angle-collected velocities in the intracranial major vessels.
Furthermore, TCDS is able to visualize intracranial lesions
in stroke [1], severe head injury [2], and other neurologi-
cal disorder cases [3]. Utilizing ultrasound contrast agents
(UCA), TCDS has been able to evaluate brain tissue perfusion
non-invasively, particularly in ischemic stroke patient inves-
tigations [4,5]. Possibilities of quantitative measurements
have been evaluated in an identical way to neuroradio-
logical perfusion imaging, based on the bolus dye-dilution
principle. However, quantitative reliability has not yet been
established, due to problems of skull- and depth-dependent
ultrasound attenuation, shadowing effects, bubble satura-
tion, and low data reproducibility (the latter due to UCA
administration methods, transducer ﬁxation, data analysis,
etc.) [4,5].
Transducer holders or probe ﬁxation devices for conven-
tional TCD monitoring have been introduced into clinical
settings [6—9]. However, a transducer holder for TCDS has
yet to be clinically introduced. We have developed and
improved such a transducer holder (Sonopod) (Fig. 1) for
TCDS monitoring via both temporal and foraminal windows
(TW and FW) (Fig. 2).
To overcome the inherent problems and establish the
clinical signiﬁcance of transcranial ultrasound perfusion
imaging, we have clinically introduced the Sonopod for
TCDS monitoring [10,11] and evaluated acetazolamide
(ACZ) vasoreactivity [12,13]. The objective of this study
is to clarify clinical usefulness and identify problems in
TCDS-Sonopod monitoring in the evaluation of brain tissue
perfusion.igure 2 TCDS-Sonopod monitoring in sitting position via both
emporal (a) and foraminal (b) windows.
aterial and methods
rain tissue perfusion monitoring was evaluated in 11
atients (ages 31—94, mean 66). Details of patient demo-TIC base-line drift during
monitoring
4 (7 TIC analyses)
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Figure 4 Hand-held monitoring via the left temporal windows
utilizing second harmonic imaging (SHI) and power modulation
imaging (PMI). Hand-held monitoring of brain tissue perfusion
via the left TW utilizing SHI (a) and PMI (b) are depicted in a
post-operative patient with an anterior communicating artery
aneurysm. TICs derived from the ﬁve ROIs, placed in the bilat-
eral BG and Th, and contra-lateral TL, are shown in the lower
panels. TICs have drifted from the base-line and are unstable
due to patient’s movements.
Figure 5 Sonopod acetazolamide (ACZ) vasoreactivity test
utilizing PMI. Sonopod monitoring of brain tissue perfusion viaigure 3 TCDS-Sonopod monitoring in supine position via the
emporal window.
econd harmonic imaging (SHI) in the initial two cases were
valuated in the supine position via TWs (Fig. 3). Both
maging types were visualized by an integrated backscat-
er method. The transmitting and receiving frequencies of
MI and SHI were 1.7/1.7MHz and 1.3/2.6MHz, respec-
ively. The investigation depth was 16 cm with a focus of
cm. Settings were mechanical index 1.6, system gain 75,
nd compression 70. ACZ cerebral vasoreactivity, before
nd after 500mg Diamox® intravenous injection, was eval-
ated in 10 cases utilizing a SONOS5500 S3 transducer
Philips Electronics Japan, Ltd.) installed in the Sonopod.
ime—intensity curves (TICs) on the diencephalic horizontal
lain were evaluated before and after ACZ in ﬁve regions
f interest (ROI); bilateral basal ganglia (BG) and thalamus
Th), and contra-lateral temporal lobe (TL). A total of 30
ICs with a duration of 10min via the bilateral (ﬁve cases)
nd unilateral (ﬁve cases) TWs were analyzed before and
fter ACZ.
esults
and-held monitoring utilizing PMI and SHI
onventional SHI and PMI utilizing hand-held monitoring
ere compared in two cases. In the visualization of the
ontralateral hemispheres via the unilateral TWs, PMI was
uperior to SHI as shown in the upper panels of Fig. 4a and
. As shown in the lower panels of the quantitative TIC
valuations in both PMI and SHI, peak intensity (PI) in the
ontralateral hemisphere ROIs was lower than in the ipsi-
ateral hemisphere ROIs. During hand-held monitoring, TICs
ere not always stable in all cases and drifted from the
ase-line due to patients’ movements as shown in the lower
anels of Fig. 4.
onopod ACZ monitoring utilizing PMI
ll patients could be ﬁtted and monitored continuously
y one examiner. Brain tissue perfusion could be precisely
uantiﬁed before/after ACZ in the same ROI as shown in
ig. 5. Due mainly to patient’s movements, drifts from the
ase-line were observed in the TICs of 4 (seven TIC analyses)
the right TW utilizing PMI before (a) and after (b) ACZ adminis-
tration, demonstrated in a postoperative patient with chronic
subdural hematoma. TICs are completely stable during 10min
of monitoring.
Brain tissue perfusion monitoring using Sonopod for transcranial
Figure 6 Sonopod PMI monitoring before ACZ administration.
Sonopod PMI monitoring of brain tissue perfusion via the left
TW before ACZ administration is shown in a patient with right
putaminal hemorrhage. TICs have drifted from the baseline due
to patients’ movements, but have been returned to the base-
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tline easily through readjustment of ﬁxed-probe positions during
monitoring.
out of 10 (30 TIC analyses) patients. However, ﬁxed-probe
shifts due to patients’ movements during monitoring were
easily re-adjustable and the TICs could be returned to
the baseline in all patients as shown in Fig. 6. Regard-
ing contralateral TW monitoring in the ﬁve bilaterally ACZ
examined patients, it was not possible to evaluate precisely
in the same ROI locations due to Sonopod re-ﬁxation.
Discussion
Transducer holder for TCD and TCDS
Transducer holders or probe ﬁxation devices for conven-
tional TCD monitoring have been introduced into clinical
settings. Previously, for the examination of neonates, a
hood-like probe ﬁxation device via the transfontanellar win-
dow has been investigated [14]. Trials in adult patients have
focused not only on the middle cerebral artery (MCA) via
the TWs [7,15], but also in the vertebrobasilar arteries via
the FW for high intensity transient signals (HITS) monitoring
[16]. More recently, a commercially available head-frame
(Marc 600, Spencer Technologies) for monitoring via the
TWs has been used for detection of recanalization in the
MCA during tissue plasminogen activator studies [6]. Fur-
thermore, a long-term ambulatory TCD monitoring device
placed on a spectacle frame has been introduced for HITS
detection in the MCAs via the TWs [9]. A modiﬁed head-
frame combining two Spencer Technologies’ head-frames
for both the TWs and FW has been tried for vasoreactivity
tests [8].
Our TCDS transducer ﬁxation device, the Sonopod, is
able to monitor not only via the TWs, but also via the
FW (Fig. 2). A further important advantage is long-duration
stable TCDS monitoring that implies accurate quantitative
measurements in the major cerebral arteries and brain tis-
sue. Proposed criteria for probe-holding systems include
ease of application, stability during patient movement,
low-cost, compatibility with multiple probes, comfort and
t
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urability [7]. The durability of a prototype of this trans-
ucer, the Sonopod, has been proven, with no problems
n our four-year experience. However, it is still so heavy
hat long-time TW monitoring in the sitting position will
robably result in discomfort caused by fatigue of the neck
uscles. This problem will be improved in changing mate-
ials from heavy stainless steel to light weight aluminum,
itanium, or similar. For FW monitoring, the Sonopod is
nable to be applied in a supine position, therefore patients
hould be instructed to lie down semi-laterally. It is nec-
ssary to tighten four screws during setup of the Sonopod
nd this may prove a slight time-consuming drawback while
earching for appropriate location of vessels or anatomical
laces. In our experience however, we were usually ready
or monitoring in around 5—10min. Improvements of the
onopod have been planned for the SONOS 5500 S3 trans-
ucer (Philips), compatibility with multiple probes and costs
f marketing the products should be conﬁrmed in the near
uture.
omparison of SHI and PMI
ince the clinical introduction of transcranial ultrasound
erfusion imaging of brain tissue, depth dependant ultra-
ound attenuation has been the most challenging problem
or qualitative and quantitative evaluation [17,18]. In our
tudy, signiﬁcant depth dependant PI attenuation on the TICs
as observed in both image types, particularly in the con-
ralateral hemisphere. In the pioneering work utilizing SHI
ith Levovist® by Postert et al. [17], not only PI but also
he area under the TIC was shown to be signiﬁcantly higher
n the BG and white matter ROIs than in the Th ROI. Fur-
hermore, SHI utilizing an alternative UCA (Optison) showed
igniﬁcantly higher Th ROI in the ipsilateral hemisphere than
n the contralateral hemisphere [18]. More recent studies
tilizing phase-inversion harmonic imaging (PIHI) utilizing
ptison and SonoVue [19] showed typical depth dependant PI
ttenuation in the contralateral hemisphere rather than the
psilateral hemisphere in bilateral or unilateral (ipsilateral)
pproaches. A bilateral approach utilizing PIHI [19,20] has
een suggested for evaluating contralateral hemispheres.
ur previous study of ultrasound perfusion imaging also
howed that PMI utilizing transient response high power
mages is superior to conventional SHI in evaluation of
he contra-lateral cerebral hemisphere [21]. This study
econﬁrmed that result. However, limitations of the con-
ralateral approach, e.g. shadowing [19], have been pointed
ut [5].
CZ vasoreactivity utilizing PMI
n order to overcome the problems in quantifying brain tissue
erfusion, e.g. depth dependant ultrasound attenuation, we
ave applied transcranial ultrasound perfusion imaging to
he ACZ vasoreactivity test [10,13]. In ACZ vasoreactivity
ests, the same ROI placements before and after ACZ are
ery important for accurate quantiﬁcation. From this point
f view, the Sonopod is very useful for precise quantiﬁcation
f brain tissue perfusion.
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onclusions
CDS-Sonopod monitoring succeeds in continuously and
uantitatively evaluating precise and reproducible intracra-
ial hemodynamics in the major cerebral arteries and brain
issue.
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